Foldable IOL Copolymer Composition for Stable Refractive Index

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing intraocular lens (IOL) materials face challenges such as unpredictable refractive index changes post-implantation, rapid unfolding leading to potential damage, and uncontrolled water sorption causing optical artifacts, while current high refractive index materials are less biocompatible and difficult to manufacture.

Innovation Solution

Development of a novel copolymer comprising aromatic or fused ring structures, hydrophilic monomers, and hydrophobic monomers to create nanoclusters that minimize water sorption and maintain stable optical properties, allowing for high refractive index and controlled unfolding.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If high water content hydrogel materials are used to achieve softness and flexibility, then the IOL can be folded and inserted through small incisions, but the refractive index becomes too low requiring thicker lens optics

Engineering Contradiction:
ImprovefoldabilityVSAvoidlens thickness
Core Design Contradiction:
Ease of operationVSVolume of moving object

Solution Approach 1:

The patent uses composite polymer materials combining hydrophilic monomers (for flexibility and foldability) with high refractive index monomers containing aromatic or fused ring structures. This composite approach allows the lens to achieve both softness for small-incision implantation and high refractive index to maintain thin optics, resolving the contradiction between foldability and lens thickness.

Inventive Principle:
Principle #40Composite materials

2Volume of moving object

If silicone materials are used to achieve higher refractive index, then the IOL optic can be thinner, but the lens unfolds too rapidly after insertion causing corneal damage

Engineering Contradiction:
Improvelens thicknessVSAvoidcorneal damage
Core Design Contradiction:
Volume of moving objectVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the polymer composition by incorporating specific hydrophilic monomers and crosslinking agents to control the glass transition temperature and mechanical properties. This allows the lens to maintain high refractive index for thin optics while adjusting the unfolding kinetics to be slower and more controlled, preventing corneal endothelium damage during insertion.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If low glass transition temperature acrylic materials are used to achieve high refractive index and controlled unfolding, then the lens unfolds more slowly, but water absorption causes light reflections and glistenings

Engineering Contradiction:
Improveunfolding controlVSAvoidglistenings
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent introduces hydrophobic monomers with aromatic or fused ring structures at specific locations within the polymer matrix to create local regions of high refractive index and water resistance. This local modification allows the bulk material to maintain controlled unfolding while specific regions prevent water absorption and glistenings, resolving the contradiction between unfolding control and optical stability.

Inventive Principle:
Principle #3Local quality

4Stability of the object's composition

If conventional hydrophobic acrylic materials are used to achieve high refractive index, then the lens maintains optical stability, but phase separation occurs leading to glistenings and poor optical properties

Engineering Contradiction:
Improveoptical stabilityVSAvoidphase separation
Core Design Contradiction:
Stability of the object's compositionVSObject-generated harmful factors

Solution Approach 1:

The patent employs copolymerization techniques to create homogeneous distribution of hydrophilic, hydrophobic, and high refractive index monomers throughout the polymer matrix. This homogeneous composition prevents phase separation and glistenings while maintaining high refractive index and optical stability, resolving the contradiction between optical stability and compositional uniformity.

Inventive Principle:
Principle #33Homogeneity

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The copolymer achieves stable optical properties, controlled water absorption, and high refractive index, enabling IOLs that can be folded through small incisions without hydration, reducing surgical complications and improving biocompatibility.

Implementation Method 1

post-implantation hydration of an IOL changes, sometimes unpredictably, the refractive index (RI) of the lens

Methodology Applied
Scientific EffectHydration: Absorption (physical)

Implementation Method 2

uncontrolled water sorption leading to optical artifacts like glistenings

Methodology Applied
Scientific EffectWater sorption: Sorption

Implementation Method 3

Following insertion of the IOL in an eye, the IOL returns to its original, pre-folded shape due to the memory characteristics of the soft material

Methodology Applied
Scientific EffectMemory characteristics: Shape Memory Polymer

Implementation Method 4

monomers containing aromatic or fused ring structures to increase RI

Methodology Applied
Scientific EffectRefraction: Refraction

Data Source

PatentUS12607776B2Polymers and methods for ophthalmic applications
Publication Date: 2026.04.21 KEY MEDICAL TECH

AI summary

The disclosure relates to novel methods and materials particularly useful for ophthalmic applications and to methods for making and using the same. More particularly, the disclosure relates to relatively soft, optically transparent, foldable, high refractive index materials particularly suited for use in the production of intraocular lenses, contact lenses, and other ocular implants and to methods for manufacturing and implanting IOLs made therefrom.